Some investigators have already shown the relationships among serum levels of CML and RAGE and endothelial function in established diabetic and nondiabetic subjects [25, 26], supporting our findings in this group of patients with newly diagnosed diabetes. This evidence concerns the gene AGER and chronic myelogenous leukemia, BCR-ABL1 positive.